Start Time: 16:30 January 1, 0000 5:18 PM ET Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Conference Call May 03, 2023, 16:30 PM ET Company Participants Paul Diaz - President and CEO Nicole Lambert - COO Bryan Riggsbee - CFO Mark Verratti - Chief Commercial Officer. Matthew Scalo - SVP, IR Conference Call Participants Andrew Cooper - Raymond James Dave Delahunt - Goldman Sachs John Kim - Bank of America Jack Meehan - Nephron Research Puneet Souda - SVB Jacob Krahenbuhl - Stephens Matthew Scalo Okay. ...